Prognostic assessment of patients with acute myocardial infarction treated with primary angioplasty: Implications for early discharge

Circulation

Volumn 109, Issue 22, 2004, Pages 2737-2743

  De Luca, Giuseppe ^a   Suryapranata, Harry ^a   Van't Hof, Arnoud W J ^a   De Boer, Menko Jan ^a   Hoorntje, Jan C A ^a   Dambrink, Jan Henk E ^a   Gosselink, A T Marcel ^a   Ottervanger, Jan Paul ^a   Zijlstra, Felix ^a  

^a HOSPITAL DE WEEZENLANDEN   (Netherlands)

Author keywords

Angioplasty; Cost benefit analysis; Myocardial infarction; Prognosis

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOPLASTY; ARTICLE; FEMALE; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SCORING SYSTEM; ST SEGMENT ELEVATION;

AGED; ANGIOPLASTY; COSTS AND COST ANALYSIS; FEASIBILITY STUDIES; FEMALE; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; MODELS, STATISTICAL; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; PROGNOSIS; RISK ASSESSMENT;

EID: 2942579074     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000131765.73959.87     Document Type: Article

References (24)

1. Bell HC, Parsons RW, Jamrozik KD, et al. Trends in the home management of non-fatal acute myocardial infarction in Perth, Western Australia between 1984 and 1993. Aust N Z J Med. 1995;25:204-208.
2. Muramatsu N, Liang J. Hospital length of stay in the United States and Japan: a case study of myocardial infarction patients. Int J Health Serv. 1999;29:189-209.
3. Maseri A, Rebuzzi AG, Cianflone D. Need for a composite risk stratification of patients with unstable coronary syndromes tailored to clinical practice. Circulation. 1997;96:4141-4142.
4. Morrow DA, Antman EM, Charlesworth A, et al. TIMI Risk Score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation. Circulation. 2000;102:2031-2037.
5. Lee KL, Woodlief LH, Topol E, et al. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Circulation. 1995;91:1659-1668.
6. Hillis LD, Forman S, Braunwald E. Risk stratification before thrombolyitic therapy in patients with acute myocardial infarction: the Thrombolysis in Myocardial Infarction (TIMI) Phase II co-investigators. J Am Coll Cardiol. 1990;116:313-315.
7. Rouleau JL, Talajic M, Sussex B, et al. Myocardial infarction patients in the 1990s: their risk factors, stratification and survival in Canada: the Canadian Assessment of Myocardial Infarction (CAMI) Study. J Am Coll Cardiol. 1996;27:1119-1127.
8. Normand ST, Glickman ME, Sharma RG, et al. Using admission characteristics to predict short-term mortality from myocardial infarction in elderly patients: results from the Cooperative Cardiovascular Project. JAMA. 1996;275:1322-1328.
9. Jacobs DR Jr, Kroenke C, Crow R, et al. PREDICT: a simple risk score for clinical severity and long-term prognosis after hospitalization for acute myocardial infarction or unstable angina: the Minnesota Heart Survey. Circulation. 1999;100:599-607.
10. Antoniucci D, Valenti R, Moschi G, et al. Relation between preintervention angiographic evidence of coronary collateral circulation and clinical and angiographic outcomes after primary angioplasty or stenting for acute myocardial infarction. Am J Cardiol. 2002;89:121-125.
11. DeGeare VS, Stone GW, Grines L, et al. Angiographic and clinical characteristics associated with increased in-hospital mortality in elderly patients with acute myocardial infarction undergoing percutaneous intervention (a pooled analysis of the Primary Angioplasty in Myocardial Infarction Trials). Am J Cardiol. 2000;86:30-34.
12. Morishima I, Sone T, Okumura K, et al. Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol. 2000;36:1202-1209.
13. Suryapranata H, Ottervanger JP, Nibbering E, et al. Long term outcome and cost-effectiveness of stenting versus balloon angioplasty for acute myocardial infarction. Heart. 2001;85:667-671.
14. de Boer MJ, Suryapranata H, Hoomtje JC, et al. Limitation of infarct size and preservation of left ventricular function after primary coronary angioplasty compared with intravenous streptokinase in acute myocardial infarction. Circulation. 1994;90:753-761.
15. Eisenberg MS, Cummins RO, Larsen MP. Numerators, denominators, and survival rates: reporting survival from out-of-hospital cardiac arrest. Ann J Emerg Med. 1991;9:544-546.
16. Newby LK, Eisenstein EL, Califf RM, et al. Cost effectiveness of early discharge after uncomplicated acute myocardial infarction. N Engl J Med. 2000;342:749-755.
17. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristics (ROC) curve. Radiology. 1982;143:29-36.
18. Grines CL, Marsalese DL, Brodie B, et al. Safety and cost-effectiveness of early discharge after primary angioplasty in low risk patients with acute myocardial infarction: PAMI-II Investigators, Primary Angioplasty in Myocardial Infarction. J Am Coll Cardiol. 1998;31:967-972.
19. Kandzari DE, Tcheng JE, Cohen DJ, et al. CADILLAC Investigators: feasibility and implications of an early discharge strategy after percutaneous intervention with abciximab in acute myocardial infarction (the CADILLAC Trial). Am J Cardiol. 2003;92:779-784.
20. Antoniucci D, Valenti R, Migliorini A, et al. Direct infarct artery stenting without predilation and no-reflow in patients with acute myocardial infarction. Am Heart J. 2001;142:684-690.
21. Stone GW, Cox D, Garcia E, et al. Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: analysis from the primary angioplasty in myocardial infarction trials. Circulation. 2001;104:624-626.
22. Antoniucci D, Valenti R, Migliorini A, et al. Relation of time to treatment and mortality in patients with acute myocardial infarction undergoing primary coronary angioplasty. Am J Cardiol. 2002;89:1248-1252.
23. Newby LK, Califf RM, Guerci A, et al. Early discharge in the thrombolytic era: an analysis of criteria for uncomplicated infarction from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) trial. J Am Coll Cardiol. 1996;27:625-632.
24. Stone G, Grines CL, Cox AD, et al, for the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Investigators. Comparison of angioplasty with stenting with or without abciximab, in acute myocardial infarction. N Engl J Med. 2002;346:957-966.